Tuesday, July 22, 2014

Deals

Basilea Pharma To Commercialize Zevtera In Europe Through Quintiles

July 21, 2014 · Leave a Comment 

  Basel, Switzerland, July 21, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that it has entered into an agreement with Quintiles (NYSE: Q) for the commercialization of Zevtera®/Mabelio® (ceftobiprole medocaril) in Europe. Under the agreement, Quintiles will provide commercial services including a dedicated field force, medical science liaisons, and market access support in selected countries. “At a time when antibiotic resistance is a major healthcare threat throughout Europe, we are very pleased to be launching Zevtera/Mabelio, a new broad-spectrum antibiotic also covering... [Read the full story]

Deal News

Basilea Pharma To Commercialize Zevtera In Europe Through Quintiles

July 21, 2014 · Leave a Comment 

  Basel, Switzerland, July 21, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that it has entered into an agreement with Quintiles (NYSE: Q) for the commercialization of Zevtera®/Mabelio® (ceftobiprole medocaril) in Europe. Under the agreement, Quintiles will provide commercial services including a dedicated field force, medical science liaisons, and market access support in selected countries. “At a time when antibiotic resistance is a major healthcare threat throughout Europe, we are very pleased to be launching Zevtera/Mabelio, a new broad-spectrum antibiotic also covering... [Read the full story]

Legal

InterDigital Announces Patent License Agreement With Samsung

June 3, 2014 · Leave a Comment 

  WILMINGTON, Del., June 3, 2014 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq:IDCC), a wireless research and development company, today announced that the company’s patent licensing subsidiaries have entered into a patent license agreement with Samsung Electronics Co., Ltd. The multi-year agreement also resolves all pending litigation between the companies. The royalty-bearing license agreement sets forth terms covering the sale by Samsung of 3G, 4G and certain future generation wireless products. “We are very happy to have resolved the licensing dispute with Samsung on... [Read the full story]

Bio

LEO Pharma & KLOX Technologies strike global dermatology deal

July 15, 2014 · Leave a Comment 

  LEO Pharma A/S and KLOX Technologies Inc. (KLOX) have entered into a worldwide license and joint venture agreement, excluding Canada, to further develop and commercialize KLOX’s BioPhotonic technology platform in dermatology, which includes a CE approved treatment for moderate to severe acne.  LEO Pharma will also make an equity investment in KLOX. The deal paves the way for LEO Pharma’s first medical device therapy and first global market entry in acne, the most common skin disease affecting more than 150 million people worldwide. In turn, KLOX has gained global access for... [Read the full story]

University Tech Transfer

U-M licenses transformative sensor technology

July 1, 2014 · Leave a Comment 

  ANN ARBOR—What started as a way for a frustrated fisherman to improve fly casting could soon be used by everyone from weekend athletes to professional tennis players under a deal between the University of Michigan and the Wilson Sporting Goods Co. The Chicago-based athletic equipment manufacturer has licensed U-M-owned patents on wireless motion sensor technology from the lab of U-M mechanical engineering professor Noel Perkins. Financial terms were not disclosed. Mike Dowse, Wilson president, said the company has a rich history of delivering innovations in the sporting equipment industry... [Read the full story]

People

Boulder’s Innovation Center of the Rockies signs commercialization agreement with University of Wyoming

October 11, 2013 · Leave a Comment 

  The Innovation Center of the Rockies, a Boulder-based organization created to help research institutions commercialize technology, has entered into an agreement with the University of Wyoming, officials announced Tuesday. Financial terms of the agreement were not disclosed. The University of Wyoming is the first commercialization partner outside the state of Colorado for the nonprofit Innovation Center of the Rockies, which has inked similar deals with the University of Colorado, Colorado School of Mines, Colorado State University and the University of Denver. “I think that we’ve... [Read the full story]

Deals

Basilea Pharma To Commercialize Zevtera In Europe Through Quintiles

  Basel, Switzerland, July 21, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that it has entered into an agreement with Quintiles (NYSE: Q) for the commercialization of Zevtera®/Mabelio® (ceftobiprole medocaril) in Europe. Under the agreement, Quintiles will provide commercial services including a dedicated field force, medical... Read more of this article


Anacor Pharmaceuticals and Sandoz Enter Into a Commercialization Agreement

  PALO ALTO, Calif.–(BUSINESS WIRE)– Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that it has entered into an exclusive agreement with Sandoz Inc., a Novartis company, pursuant to which Sandoz will distribute and commercialize Anacor’s drug KERYDINTM (tavaborole) topical solution, 5% in the United States. PharmaDerm,... Read more of this article


General Patent Corporation Signs a License Agreement with SuperCom for Leighton Technologies’ Patents

  Suffern, N.Y. – July 17, 2014 − General Patent Corporation (GPC), a leading patent licensing and enforcement firm, announced today on behalf of its subsidiary, Leighton Technologies LLC (Leighton), that it signed a license agreement with SuperCom Ltd. and PureRFid, Inc. (SuperCom). As a result, SuperCom has licensed Leighton Technologies’... Read more of this article


EcoPesticides signs licensing agreement with STC.UNM

  ALBUQUERQUE, N.M., July 9, 2014 – - EcoPesticides International, Inc., has signed a licensing agreement for a novel “green” microbial-based pesticide technology with STC.UNM, the University of New Mexico’s technology transfer and economic development organization. EcoPesticides is a New Mexico-based company developing pesticides that... Read more of this article


BIAL And moksha8 Announce Exclusive License

  Wayne, PA, USA, Porto, Portugal.. July 15, 2014 – BIAL a research based international pharmaceutical company and moksha8 a leading specialty pharmaceutical company in Latin America announced today an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix® / (Exalief®) in Brazil and Mexico for the treatment of... Read more of this article


PharmaMar and Chugai Pharma Marketing Enter into a License and Commercialization Agreement

  Madrid, Spain, July 14, 2014 and Tokyo, Japan, July 15, 2014: Zeltia and Chugai Pharmaceutical Co., Ltd. today announced that PharmaMar S.A., a wholly owned oncology subsidiary of Zeltia, and Chugai Pharma Marketing Ltd, a wholly owned subsidiary of Chugai, have entered into a license agreement where Chugai Pharma Marketing would promote PharmaMar’s... Read more of this article


LEO Pharma & KLOX Technologies strike global dermatology deal

  LEO Pharma A/S and KLOX Technologies Inc. (KLOX) have entered into a worldwide license and joint venture agreement, excluding Canada, to further develop and commercialize KLOX’s BioPhotonic technology platform in dermatology, which includes a CE approved treatment for moderate to severe acne.  LEO Pharma will also make an equity investment... Read more of this article


Ecosphere Technologies Announces Technology Licensing Agreement With Brasil Clean Energy

  STUART, Fla., July 15, 2014 (GLOBE NEWSWIRE) — Ecosphere Technologies, Inc. (OTCBB:ESPH), a U.S. technology licensing and innovative manufacturing company, today announced that it has signed an exclusive technology licensing and equipment purchase agreement with Brasil Clean Energy, a Brazilian environmental services company, to deploy... Read more of this article


Novartis to license Google “smart lens” technology

  Basel, Switzerland, July 15, 2014 - Novartis announced that its eye care division Alcon has entered into an agreement with a division of Google Inc. to in-license its “smart lens” technology for all ocular medical uses. The agreement with Google[x], a team within Google that is devoted to finding new solutions to big global problems,... Read more of this article


Codexis Signs Platform Technology License Agreement With GSK

  REDWOOD CITY, Calif., July 14, 2014 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading developer of biocatalysts for the pharmaceutical and fine chemical industries, today announced the signing of a platform technology license agreement with GlaxoSmithKline (GSK). Under the terms of the agreement, Codexis granted GSK a license to... Read more of this article


More Posts From Deals

Legal

InterDigital Announces Patent License Agreement With Samsung

  WILMINGTON, Del., June 3, 2014 (GLOBE NEWSWIRE) — InterDigital, Inc.... 


Acacia Subsidiary Enters into Settlement and Patent License Agreement with PNC Bank, N.A.

  Newport Beach, Calif. – (BUSINESS WIRE) March 31, 2014 – Acacia Research... 


More Posts From Legal

University Tech Transfer

U-M licenses transformative sensor technology

  ANN ARBOR—What started as a way for a frustrated fisherman to improve fly... 


Cardiovate Signs Patent & License Agreement For TESAR, Hires New CEO

Two years after its launch, start-up biotechnology company Cardiovate has acquired... 


More Posts From University Tech Transfer